Alx Property Plant And Equipment Gross vs Net Working Capital Analysis
ALXO Stock | USD 10.94 0.29 2.72% |
Alx Oncology financial indicator trend analysis is way more than just evaluating Alx Oncology Holdings prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Alx Oncology Holdings is a good investment. Please check the relationship between Alx Oncology Property Plant And Equipment Gross and its Net Working Capital accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alx Oncology Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest.
Property Plant And Equipment Gross vs Net Working Capital
Property Plant And Equipment Gross vs Net Working Capital Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Alx Oncology Holdings Property Plant And Equipment Gross account and Net Working Capital. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between Alx Oncology's Property Plant And Equipment Gross and Net Working Capital is 0.41. Overlapping area represents the amount of variation of Property Plant And Equipment Gross that can explain the historical movement of Net Working Capital in the same time period over historical financial statements of Alx Oncology Holdings, assuming nothing else is changed. The correlation between historical values of Alx Oncology's Property Plant And Equipment Gross and Net Working Capital is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Property Plant And Equipment Gross of Alx Oncology Holdings are associated (or correlated) with its Net Working Capital. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Working Capital has no effect on the direction of Property Plant And Equipment Gross i.e., Alx Oncology's Property Plant And Equipment Gross and Net Working Capital go up and down completely randomly.
Correlation Coefficient | 0.41 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Property Plant And Equipment Gross
Net Working Capital
Most indicators from Alx Oncology's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Alx Oncology Holdings current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alx Oncology Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. At this time, Alx Oncology's Issuance Of Capital Stock is very stable compared to the past year. As of the 31st of May 2024, Sales General And Administrative To Revenue is likely to grow to 11.84, while Tax Provision is likely to drop 0.00.
2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 83.6M | 127.4M | 169.4M | 177.9M | Cost Of Revenue | 736K | 1.5M | 836K | 1.4M |
Alx Oncology fundamental ratios Correlations
Click cells to compare fundamentals
Alx Oncology Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Alx Oncology fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 10.7M | 436.1M | 380.2M | 306.5M | 242.6M | 254.3M | |
Other Current Liab | 1.2M | 6.2M | 257K | 19.2M | 25.8M | 27.1M | |
Total Current Liabilities | 5.0M | 6.2M | 15.3M | 28.3M | 36.0M | 37.8M | |
Total Stockholder Equity | (276K) | (118.5M) | (202.0M) | (325.5M) | 189.7M | 199.2M | |
Other Liab | 547K | 5K | 1.8M | 53K | 61.0K | 57.9K | |
Net Tangible Assets | (70.6M) | 429.8M | 363.0M | 263.5M | 303.0M | 205.5M | |
Property Plant And Equipment Net | 860K | 52K | 3.5M | 9.8M | 10.8M | 11.4M | |
Net Debt | (3.6M) | (434.2M) | (362.9M) | (272.5M) | (5.2M) | (5.5M) | |
Retained Earnings | (72.8M) | (118.5M) | (202.0M) | (325.5M) | (486.3M) | (462.0M) | |
Accounts Payable | 3.7M | 4K | 3.8M | 8.1M | 8.6M | 4.6M | |
Cash | 9.0M | 434.2M | 363.7M | 282.9M | 22.4M | 21.3M | |
Non Current Assets Total | 867K | 1.8M | 13.2M | 35.5M | 53.9M | 56.6M | |
Cash And Short Term Investments | 9.0M | 434.2M | 363.7M | 282.9M | 182.7M | 234.8M | |
Common Stock Shares Outstanding | 36.5M | 39.8M | 40.3M | 40.7M | 43.0M | 40.8M | |
Liabilities And Stockholders Equity | 10.7M | 436.1M | (184.9M) | (282.4M) | 242.6M | 254.7M | |
Non Current Liabilities Total | 6.0M | 5K | 1.8M | 14.7M | 16.8M | 17.7M | |
Capital Surpluse | 2.1M | 548.3M | 565.0M | 589.7M | 678.2M | 375.5M | |
Other Current Assets | 256K | 1.8M | 3.4M | 4.8M | 4.9M | 2.9M | |
Other Stockholder Equity | 2.1M | 118.5M | (41K) | 804K | 675.7M | 709.5M | |
Total Liab | 11.0M | 436.1M | 17.1M | 43.0M | 52.8M | 74.9M | |
Net Invested Capital | (65.2M) | 429.8M | 363.0M | 272.9M | 199.4M | 210.5M | |
Property Plant And Equipment Gross | 860K | 52K | 3.5M | 10.2M | 12.1M | 12.7M | |
Total Current Assets | 9.8M | 434.2M | 367.0M | 271.0M | 188.7M | 234.8M | |
Accumulated Other Comprehensive Income | (1.4M) | (554.6M) | 0.0 | (845K) | 256K | 268.8K | |
Net Working Capital | 4.8M | 429.8M | 351.7M | 242.6M | 152.7M | 218.2M | |
Property Plant Equipment | 860K | 52K | 897K | 3.9M | 4.5M | 4.7M |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Trending Equities to better understand how to build diversified portfolios, which includes a position in Alx Oncology Holdings. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in interest. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Complementary Tools for Alx Stock analysis
When running Alx Oncology's price analysis, check to measure Alx Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Alx Oncology is operating at the current time. Most of Alx Oncology's value examination focuses on studying past and present price action to predict the probability of Alx Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Alx Oncology's price. Additionally, you may evaluate how the addition of Alx Oncology to your portfolios can decrease your overall portfolio volatility.
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
Stocks Directory Find actively traded stocks across global markets | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Content Syndication Quickly integrate customizable finance content to your own investment portal |
Is Alx Oncology's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Alx Oncology. If investors know Alx will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Alx Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.54) | Quarterly Revenue Growth (1.00) | Return On Assets (0.45) | Return On Equity (0.82) |
The market value of Alx Oncology Holdings is measured differently than its book value, which is the value of Alx that is recorded on the company's balance sheet. Investors also form their own opinion of Alx Oncology's value that differs from its market value or its book value, called intrinsic value, which is Alx Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Alx Oncology's market value can be influenced by many factors that don't directly affect Alx Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Alx Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Alx Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Alx Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.